Immunovant, Inc. IMVT Preferred Stock, Par or Stated Value Per Share
Preferred Stock, Par or Stated Value Per Share at other companies
Other financials
Where this comes from
Reported directly by Immunovant, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockParOrStatedValuePerShare.
The official record: Immunovant, Inc.’s 10-Q, filed February 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunovant, Inc.'s preferred stock, par or stated value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunovant, Inc.'s preferred stock, par or stated value per share?
- Immunovant, Inc. (IMVT) reported preferred stock, par or stated value per share of $0 in Q4 2025.
- How has Immunovant, Inc.'s preferred stock, par or stated value per share changed year-over-year?
- Immunovant, Inc.'s preferred stock, par or stated value per share decreased by 0.0% year-over-year, from $0 to $0.